Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease-Reference-Cited by-同舟云学术

Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease

Published:2005-04 Issue:1-2 Volume:231 Page:57-66
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Wang Xukui,Sarkar Aparajita,Cicchetti Francesca,Yu Meixiang,Zhu Aijun,Jokivarsi Kimmo,Saint-Pierre Martine,Brownell Anna-Liisa

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference71 articles.

1. Neurochemical anatomy and movement disorders;Young;Neurol. Clin.,1984

2. Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA);Ross;Medicine (Baltimore),1997

3. Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study;Witjes-Ane;J. Neuropsychiatry Clin. Neurosci.,2003

4. Genetics and molecular biology of Huntington's disease;Albin;Trends Neurosci.,1995

5. Changes in Ca(2+)-binding proteins in human neurodegenerative disorders;Heizmann;Trends Neurosci.,1992

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal study of neurochemical, volumetric and behavioral changes in Q140 & BACHD mouse models of Huntington’s disease;2024-02-21

2. A simple assay for direct visual and colorimetric sensing application of cysteamine using Au@Ag core-shell nanoparticles;Optical Materials;2020-11

3. Colorimetric determination of cysteamine based on the aggregation of polyvinylpyrrolidone-stabilized silver nanoparticles;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2020-08

4. Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo;Bioscience Reports;2018-09-05

5. TSPO–PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington’s disease: preclinical evidence with the p75NTR ligand LM11A-31;Human Molecular Genetics;2018-05-30